Pier Capital LLC Acquires 145,703 Shares of Ardent Health, Inc. $ARDT

Pier Capital LLC boosted its holdings in shares of Ardent Health, Inc. (NYSE:ARDT) by 33.5% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 580,620 shares of the company’s stock after acquiring an additional 145,703 shares during the period. Ardent Health accounts for about 1.2% of Pier Capital LLC’s investment portfolio, making the stock its 26th largest holding. Pier Capital LLC owned about 0.41% of Ardent Health worth $7,693,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of ARDT. Sei Investments Co. grew its holdings in Ardent Health by 4.4% in the third quarter. Sei Investments Co. now owns 180,523 shares of the company’s stock worth $2,392,000 after purchasing an additional 7,625 shares during the period. UBS Group AG lifted its holdings in shares of Ardent Health by 1,394.0% during the third quarter. UBS Group AG now owns 127,827 shares of the company’s stock valued at $1,694,000 after purchasing an additional 119,271 shares during the last quarter. Legal & General Group Plc lifted its holdings in shares of Ardent Health by 984.1% during the third quarter. Legal & General Group Plc now owns 23,265 shares of the company’s stock valued at $308,000 after purchasing an additional 21,119 shares during the last quarter. First Trust Advisors LP boosted its position in shares of Ardent Health by 2.4% in the 3rd quarter. First Trust Advisors LP now owns 201,250 shares of the company’s stock worth $2,667,000 after purchasing an additional 4,788 shares in the last quarter. Finally, Vanguard Group Inc. grew its stake in shares of Ardent Health by 44.5% in the 3rd quarter. Vanguard Group Inc. now owns 1,352,676 shares of the company’s stock worth $17,923,000 after buying an additional 416,348 shares during the last quarter.

Ardent Health Trading Up 1.9%

NYSE:ARDT opened at $9.20 on Friday. The stock has a market cap of $1.32 billion, a price-to-earnings ratio of 9.58 and a beta of 0.46. The company has a quick ratio of 1.95, a current ratio of 2.08 and a debt-to-equity ratio of 0.67. The company’s 50 day moving average price is $9.01 and its 200-day moving average price is $10.89. Ardent Health, Inc. has a 52 week low of $8.07 and a 52 week high of $15.48.

Ardent Health (NYSE:ARDT) last announced its quarterly earnings data on Wednesday, March 4th. The company reported $0.32 earnings per share for the quarter, missing analysts’ consensus estimates of $0.35 by ($0.03). The firm had revenue of $1.61 billion during the quarter, compared to analysts’ expectations of $1.63 billion. Ardent Health had a return on equity of 14.46% and a net margin of 2.15%.Ardent Health has set its FY 2026 guidance at 0.900-1.270 EPS. On average, equities research analysts forecast that Ardent Health, Inc. will post 1.23 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research firms recently weighed in on ARDT. Mizuho reduced their price objective on Ardent Health from $20.00 to $12.00 and set an “outperform” rating for the company in a research report on Thursday, December 18th. Guggenheim cut their target price on Ardent Health from $18.00 to $15.00 and set a “buy” rating on the stock in a research note on Tuesday, November 18th. UBS Group reduced their price target on Ardent Health from $14.50 to $14.00 and set a “buy” rating for the company in a report on Thursday, December 18th. Leerink Partners lowered their price target on Ardent Health from $16.00 to $15.00 and set an “outperform” rating for the company in a research report on Friday, March 6th. Finally, KeyCorp cut shares of Ardent Health from an “overweight” rating to a “sector weight” rating in a research note on Monday, November 17th. Seven research analysts have rated the stock with a Buy rating, four have issued a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, Ardent Health presently has an average rating of “Hold” and an average price target of $14.25.

Ardent Health Profile

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.